Clinical Trial Detail

NCT ID NCT03366766
Title Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University
Indications

lung non-small cell carcinoma

Therapies

Cisplatin + Gemcitabine + Nivolumab

Cisplatin + Nivolumab + Pemetrexed Disodium

Age Groups: adult senior

Additional content available in CKB BOOST